0001209191-20-031023.txt : 20200520
0001209191-20-031023.hdr.sgml : 20200520
20200520184527
ACCESSION NUMBER: 0001209191-20-031023
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200518
FILED AS OF DATE: 20200520
DATE AS OF CHANGE: 20200520
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDBERG MURRAY A
CENTRAL INDEX KEY: 0001226435
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36152
FILM NUMBER: 20899421
MAIL ADDRESS:
STREET 1: 2030 MAIN STREET, SUITE 1500
CITY: IRVINE
STATE: CA
ZIP: 92614
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001337553
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203109565
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4301 EMPEROR BOULEVARD
STREET 2: SUITE 400
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: (919) 237-5300
MAIL ADDRESS:
STREET 1: 4301 EMPEROR BOULEVARD
STREET 2: SUITE 400
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-18
0
0001337553
AERIE PHARMACEUTICALS INC
AERI
0001226435
GOLDBERG MURRAY A
C/O AERIE PHARMACEUTICALS, INC.
4301 EMPEROR BLVD., SUITE 400
DURHAM
NC
27703
1
0
0
0
Common Stock
2020-05-18
4
M
0
28000
3.15
A
36050
D
Stock Option (right to buy)
3.15
2020-05-18
4
M
0
28000
0.00
D
2023-09-12
Common Stock
28000
0
D
This option is fully vested and exercisable.
/s/ John LaRocca, Attorney-in-Fact for Murray A. Goldberg
2020-05-20